These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 18638431)

  • 21. Gout-associated uric acid crystals activate the NALP3 inflammasome.
    Martinon F; Pétrilli V; Mayor A; Tardivel A; Tschopp J
    Nature; 2006 Mar; 440(7081):237-41. PubMed ID: 16407889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colchicine-responsive protracted gouty arthritis with systemic inflammatory reactions.
    Nonaka F; Migita K; Haramura T; Sumiyoshi R; Kawakami A; Eguchi K
    Mod Rheumatol; 2014 May; 24(3):540-3. PubMed ID: 24533551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An update on the treatment options for gout and calcium pyrophosphate deposition.
    Choy G
    Expert Opin Pharmacother; 2005 Nov; 6(14):2443-53. PubMed ID: 16259576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rhein, An Anthraquinone Drug, Suppresses the NLRP3 Inflammasome and Macrophage Activation in Urate Crystal-Induced Gouty Inflammation.
    Chang WC; Chu MT; Hsu CY; Wu YJ; Lee JY; Chen TJ; Chung WH; Chen DY; Hung SI
    Am J Chin Med; 2019; 47(1):135-151. PubMed ID: 30612459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GEF-H1 Is Required for Colchicine Inhibition of Neutrophil Rolling and Recruitment in Mouse Models of Gout.
    Fine N; Gracey E; Dimitriou I; La Rose J; Glogauer M; Rottapel R
    J Immunol; 2020 Dec; 205(12):3300-3310. PubMed ID: 33199537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics considerations for gout treatments.
    Richette P; Frazier A; Bardin T
    Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):949-57. PubMed ID: 24809930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.
    Khanna D; Khanna PP; Fitzgerald JD; Singh MK; Bae S; Neogi T; Pillinger MH; Merill J; Lee S; Prakash S; Kaldas M; Gogia M; Perez-Ruiz F; Taylor W; Lioté F; Choi H; Singh JA; Dalbeth N; Kaplan S; Niyyar V; Jones D; Yarows SA; Roessler B; Kerr G; King C; Levy G; Furst DE; Edwards NL; Mandell B; Schumacher HR; Robbins M; Wenger N; Terkeltaub R;
    Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1447-61. PubMed ID: 23024029
    [No Abstract]   [Full Text] [Related]  

  • 28. [Diagnosis of gout].
    Pascual Gómez E
    Med Clin (Barc); 2004 Dec; 123(20):798. PubMed ID: 15607075
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of acute gouty arthritis: one physician's approach and where this management stands relative to developments in the field.
    Wortmann RL
    Curr Rheumatol Rep; 2004 Jun; 6(3):235-9. PubMed ID: 15134604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mice with miR-146a deficiency develop severe gouty arthritis via dysregulation of TRAF 6, IRAK 1 and NALP3 inflammasome.
    Zhang QB; Qing YF; Yin CC; Zhou L; Liu XS; Mi QS; Zhou JG
    Arthritis Res Ther; 2018 Mar; 20(1):45. PubMed ID: 29544526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Canakinumab for the Patient With Difficult-to-Treat Gouty Arthritis: Review of the Clinical Evidence.
    Bardin T
    Joint Bone Spine; 2015 Oct; 82 Suppl 1():eS9-16. PubMed ID: 26717801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of melanocortin receptors in the regulation of gouty inflammation.
    Montero-Melendez T; Patel HB; Perretti M
    Curr Rheumatol Rep; 2011 Apr; 13(2):138-45. PubMed ID: 21243457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of acute gout: a systematic review.
    Khanna PP; Gladue HS; Singh MK; FitzGerald JD; Bae S; Prakash S; Kaldas M; Gogia M; Berrocal V; Townsend W; Terkeltaub R; Khanna D
    Semin Arthritis Rheum; 2014 Aug; 44(1):31-8. PubMed ID: 24650777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal-associated arthritis in the elderly.
    Agudelo CA; Wise CM
    Rheum Dis Clin North Am; 2000 Aug; 26(3):527-46, vii. PubMed ID: 10989511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal-induced neutrophil activation: X. Proinflammatory role of the tyrosine kinase Tec.
    Popa-Nita O; Marois L; Paré G; Naccache PH
    Arthritis Rheum; 2008 Jun; 58(6):1866-76. PubMed ID: 18512796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct Binding to NLRP3 Pyrin Domain as a Novel Strategy to Prevent NLRP3-Driven Inflammation and Gouty Arthritis.
    Yang G; Lee HE; Moon SJ; Ko KM; Koh JH; Seok JK; Min JK; Heo TH; Kang HC; Cho YY; Lee HS; Fitzgerald KA; Lee JY
    Arthritis Rheumatol; 2020 Jul; 72(7):1192-1202. PubMed ID: 32134203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN).
    Dalbeth N; Bardin T; Doherty M; Lioté F; Richette P; Saag KG; So AK; Stamp LK; Choi HK; Terkeltaub R
    Nat Rev Rheumatol; 2017 Sep; 13(9):561-568. PubMed ID: 28794514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the cytokine network among tumor necrosis factor alpha, interleukin-1beta, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystal-induced rabbit arthritis.
    Matsukawa A; Yoshimura T; Maeda T; Takahashi T; Ohkawara S; Yoshinaga M
    Lab Invest; 1998 May; 78(5):559-69. PubMed ID: 9605181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Gout and other crystal-induced arthritides].
    Manger B
    Dtsch Med Wochenschr; 2012 Aug; 137(31-32):1579-81. PubMed ID: 22786675
    [No Abstract]   [Full Text] [Related]  

  • 40. Colchicine-induced rhabdomyolysis.
    Altman A; Szyper-Kravitz M; Shoenfeld Y
    Clin Rheumatol; 2007 Dec; 26(12):2197-2199. PubMed ID: 17619811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.